Rodrigues Rosane S, Setti Amanda S, Braga Daniela P A F, Valente Fernanda M, Iaconelli Assumpto, Borges Edson
Fertility - Centro de Fertilização Assistida, São Paulo, SP, Brazil.
Instituto Sapientiae - Centro de Estudos e Pesquisa em Reprodução Assistida, São Paulo, SP, Brazil.
JBRA Assist Reprod. 2014 Jun 27;18(3):76-79. doi: 10.5935/1518-0557.20140011.
To evaluate a comfortable short protocol with GnRH agonist (GnRHa) in alternate days, with a step down method of gonadotropins administration associated with hCG microdose for young patients undergoing intracytoplasmic sperm injection.
This study evaluated 89 ICSI cycles performed in female patients aged <36 years. Patients were submitted to a short protocol with GnRHa schedule in the study group (n= 25) and to a long pituitary suppression protocol in the control group (n=64).
The total dose of rFSH administered as well as estradiol levels on the day of hCG trigger were significantly lower in the short protocol group. There were no significant differences between the groups regarding the fertilization, high-quality embryos, implantation, pregnancy and miscarriage rates. However, mean ovarian stimulation cost (GnRHa short group: $2,397 ± $870.3 and control group: $3,197 ± $658.9, P <0.001) and mean ovarian stimulation cost per pregnancy (GnRHa short group: ($4,993 ± $1,813 and control group: $9,743 ± $2,008, P <0.001) were significantly lower in the GnRHa short group as compared to the control group.
In patients with normal ovarian response, pituitary suppression with a GnRHa short protocol in alternate days is less costly, requires lower gonadotropins doses and results in similar implantation and pregnancy rates as compared to a GnRHa long protocol.
评估一种适用于年轻患者的促性腺激素释放激素激动剂(GnRHa)隔日使用的简便短方案,该方案采用促性腺激素递减给药方法并联合人绒毛膜促性腺激素(hCG)小剂量注射,用于接受卵胞浆内单精子注射的患者。
本研究评估了89个在年龄小于36岁女性患者中进行的卵胞浆内单精子注射(ICSI)周期。研究组(n = 25)的患者采用GnRHa短方案,对照组(n = 64)的患者采用垂体长期抑制方案。
短方案组在hCG扳机日时促卵泡生成素(rFSH)的总给药剂量以及雌二醇水平显著更低。两组在受精、优质胚胎、着床、妊娠和流产率方面无显著差异。然而,GnRHa短方案组的平均卵巢刺激成本(GnRHa短方案组:2397美元±870.3美元,对照组:3197美元±658.9美元,P < 0.001)以及每例妊娠的平均卵巢刺激成本(GnRHa短方案组:4993美元±1813美元,对照组:9743美元±2008美元,P < 0.001)与对照组相比显著更低。
对于卵巢反应正常的患者,与GnRHa长方案相比,GnRHa隔日短方案垂体抑制成本更低,所需促性腺激素剂量更低,且着床率和妊娠率相似。